Clinical Trials Browser

Phase 2/3 × Esophagectomy × Gastrointestinal × Clear all

NCT05213312 2022-06-15

Study of Neoadjuvant Nivolumab or Placebo Plus Chemotherapy Followed by Surgery and Adjuvant Treatment in Subjects With Resectable ESCC

Phase 2/3 Unknown

Gastrointestinal

Esophageal Squamous Cell Carcinoma

NCT03623737 2022-06-07

Comparing Paclitaxel/Cisplatin and Cisplatin/5-fluorouracil in Neo-CRT for ESCC

Phase 2/3 Unknown

Gastrointestinal

Esophageal Squamous Cell Carcinoma